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Abstract

Pseudomonas aeruginosa mutants PA0686, PA3102, PA3103, and PA5210

carry transposon insertions in uncharacterized genes in the PA01 background.

The biofilms formed by these mutants show different phenotypes than PA01,

their wild-type counterpart. BLAST searches and phylogenomic mapping

tools indicate that protein products of the mutated genes are involved in P.

aeruginosa type-II secretion, which is linked to twitching motility. In this

study, 96-well microtitre plate biofilm assays, UV/visible spectrophotometer

analysis, and motility assays were used to demonstrate a link between type-

II secretion, twitching motility and biofilm formation. The results show that

the PA5210 mutant forms a biofilm that is less compact than the wild-type,

while PA0686 forms a faint biofilm. Also, the motility assays support our

hypothesis that these mutants are defective in twitching motility.
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Introduction

Pseudomonas aeruginosa (PA) is an opportunistic pathogen that

causes persistent infection in humans by forming a highly organized

microbial community called a biofilm. The biofilm is formed when

planktonic (free-swimming) cells attach to biotic and abiotic surfaces under

certain environmental conditions. These surface-attached cells are 10-1000

times more resistance to traditional antibiotic therapy than planktonic cells

(Drenkard, 2003). P. aeruginosa biofilms are linked to 10% to 20% of

nosocomial infections, the most common sites of biofilm formation being

catheter lines, burn wounds, cystic fibrosis lung tissue, and organ transplant

sites (Bodey, Bolivar, Fainstein & Jadeja, 1983; Miller & Ahearn, 1987).

Also, P. aeruginosa biofilms are a frequent cause of otitis externa in

swimmers and osteomyelitis in puncture wounds of the feet (Sarlangue,

Brissaud & Labreze, 2006).

The latter facts strengthen the argument that

ii

understanding the genetics behind biofilm formation by P. aeruginosa is

important in the medical field.

The most problematic factor in the treatment of P. aeruginosa

infections is the resistance of its biofilm to antimicrobial agents. Thus, the

treatment would be more effective if it is to include a system designed to

weaken the formation, structure, or attachment of the biofilm during its

development. Profound changes occur in the gene expression profile of free-

living P. aeruginosa during biofilm formation in response to appropriate

environmental signals (O’Toole & Kolter, 1998a; Sauer & Camper, 2001).

Data generated using DNA microarray analysis show that about 70 P.

aeruginosa genes (approximately 1% of genes analyzed) are differentially

expressed in biofilms with respect to planktonic cells grown in chemostat

cultures (Drenkard, 2003). These small numbers of important genes that are

induced in biofilms include bacteriophage genes and genes that code for
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proteins involved in translation, metabolism, membrane transport/secretion,

and

gene

regulation

(Drenkard,

2003).

Figure 1- Steps in P. aeruginosa biofilm formation (O’Toole, 2007)

The development of P. aeruginosa biofilms under static assay

conditions can be described in four processes, as shown in figure 1. At first,

planktonic cells are transported and reversibly attach to a surface substrate.

Then, the surface-attached cells irreversibly form a monolayer on the surface.

Subsequently, the cells in the monolayer begin to migrate toward

aggregation centers known as microcolonies. Lastly, these microcolonies

mature

into

complex

mushroom-shaped

structures

covered

by
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exopolysaccharide matrix and some cells break from the biofilm as

planktonic cells to be dispersed (O’Toole el at., 2000; O’Toole and Kolter,

1998a).

The goal of our research is to uncover and characterize those genes

required for biofilm formation in the pathogenic organism P. aeruginosa.

Through phenotypic characterization of strains carrying disrupted genes,

including an analysis of their biofilm phenotypes, a gene’s role in biofilm

formation can be determined. A wide range of medical applications may

come from this because treatment in one organism may be effective across a

broad evolutionary spectrum. There are significant morphological and

genetic similarities between most biofilms, even those of very different

bacterial species (Garza, 2006).

George O’Toole provided P. aeruginosa strain PA01 mutants that

carry transposon insertions in previously uncharacterized genes. In order to
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determine the function of these disrupted genes, a traditional genome

annotation approach (BLAST) was used to compare each ORF within the

genome to GenBank®, an official NIH genetic sequence database which

contains more than 100 gigabases of an annotated collection of all publicly

available DNA sequences (NCBI, 2007). The BLAST search annotated the

uncharacterized clusters of genes in PA01 strain to be involved in type-II

secretion. Type-II secretion is the mechanism by which Gram-negative

organisms such as P. aeruginosa export pili components, virulence factors,

toxins, and hydrolytic enzymes that may contribute to biofilm maturation

(Russel, M. 1998).

Following the BLAST search, phylogenomic mapping was used to

identify possible functional interactions between type-II secretion genes and

other genes on the P. aeruginosa chromosome. The phylogenomic map

groups P. aeruginosa genes/proteins on the basis of coinheritance, which is a
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strong indicator of shared function (Srinivasan et al, 2005).

According to

the phylogenomic map, the genes for type-II secretion are co-inherited with

genes required for twitching motility, a surface-based motility that is known

to be important for biofilm formation.

Thus, based on the phylogenomic

map, the type-II secretion mutant strains under study are predicted to have a

twitching motility and perhaps biofilm phenotypes.

Bacterial motility is required for both biofilm pathogenesis and

attachment to biotic and abiotic surfaces. Pseudomonas aeruginosa bacteria

swim in liquid by using flagella to move on surfaces by means of type IV

pili, and the extension and retraction of type IV pili powers twitching

motility, a surface-associated movement that propels bacteria across solid or

semi-solid substrates (Semmler et al., 1999, Skerker & Berg, 2001). From

the results from biofilm experiments conducted by O’Toole and Kolter

(1998a) on biofilm formation by P. aeruginosa PA14, it is speculated that
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swimming motility might enable the bacteria to overcome repulsive forces at

the surface–water interface so that they reach the surface, and that the

microcolonies may be formed by twitching motility-driven cell aggregation.

The assessment of twitching and swarming motility of P. aeruginosa utilizes

motility assays where the phenotype of the twitching motility defective

mutants are distinguished from the wild-type on 1.5% agar media, whereas

swarming motility phenotype is assessed using softer, 0.4% agar.

The 96-well microtitre plate assay is used to qualitatively

characterize the progress of biofilm development. This static assay is often

preferred over continuous-flow methods due to the simplicity of the

protocols and its cost-effective nature (Garza, 2006). Also, the 96-well

format has the capacity to screen a large number of bacterial strains at once

and is a good visual indicator of adherent biomass stained in crystal violet

(CV) dye (O’Toole & Kolter, 1998a and b). The results from the 96-well
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microtitre plate assay indicated the influence of the type-II secretion

pathway in biofilm formation.

Spectrophotometry is used for quantitative measurement of the

biofilm formed in the 96-well plate assay. The spectrophotometer measures

the amount of biofilm by screening the quantity of light with a specific

wavelength that passes through a medium. According to Beer's law, the

amount of light absorbed by a medium is proportional to the concentration

of the absorbing material or solute present (Fankhauser, 2005). Thus, the

concentration of a CV-stained solute in ethanol is determined by measuring

the absorbency of light at wavelength of 600nm, which is the maximum

absorption wavelength of CV.

The resistance of a biofilm can be determined by the antibacterial

resistance assay. The quantity of the mutant P. aeruginosa cells after the

antibacterial treatment is compared to that of the wild-type cells treated in
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the same way.

Mutant strains with strongest phenotypical deviation (in both

biofilm formation and antibacterial resistance) compared to the wild-type are

selected for a more detailed analysis, while further characterization of the

mutants with subtle biofilm defects is postponed due to time limitation.

The general impact of the research is to better understand the

genetics behind pathogenic biofilm formation. The practical application of

this information is the potential discovery of new targets for antimicrobial

agents, and thus, new potential treatments for infections caused by P.

aeruginosa and other biofilm-forming pathogens.

x
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MATERIALS AND METHODS

Bacterial strains and culture conditions

The microorganism used in this study was the opportunistic pathogenic

bacterium P. aeruginosa.

The strain that was used is PA01.

Four PA01

mutants were also used. P. aeruginosa was grown on plates containing LB

and 1.5% agar. Strains were grown in a 37°C incubator overnight. Then, one

colony was picked with a pipette tip and the colony was dispersed into 5-ml

of liquid LB in a sterile glass tube. The liquid culture was incubated in a

37°C shaker overnight.

Microtitre plate biofilm assay

This method was designed by O’Toole and Kolter, 1998b. M63 minimal

media (M63, MgSO4, Glucose, CAA)) is prepared with 5 ml of 1M M63, 5

ul of 1M MgSO4 (1mM dilution), 50 ul of 20% glucose (0.2% dilution), and

125 ul of Casamino acids (0.5% dilution) in a glass tube. Then, 50 ul (1:100
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dilutions) of the overnight liquid cultures of the wild-type and the mutants

were added to the M63 minimal media cocktail.

One hundred microliterl

of M63 minimal media cocktail + bacteria cells was placed into each well of

96-well microtitre plates. The microtitre plates were sealed with Parafilm®

to prevent evaporation during the incubation period. The Parafilm® sealed

microtitre plates were placed in the 37°C incubator for the desired amount of

time (in our case, 2hr, 4hr, 6hr, 8hr, 12hr, and 24hr). By using different

incubation times, we were able to determine the number of hours required

for the P. aeruginosa strain to fully attach to the surface.

Following incubation, the planktonic cells in the wells were removed by

turning over the plates and shaking the liquid into an empty plastic container.

Afterwards, the 96-well plates were repeatedly submerged in a small tub of

deionized water to wash out the planktonic bacteria that did not form a

biofilm. The removal of unattached cells from the wells was intended to
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reduce the number planktonic cells that stain with Crystal Violet (CV);

planktonic cells should not be included in calculations of biofilm cell mass.

Each well was stained with 125

l of 0.1% CV dye and the plates were

incubated at room temperature for 15-30 minutes. After that, the CV in the

wells was dumped into a waste plastic container and the wells were rinsed 3-

4 times with deionized water. The plates were then blotted on a stack of

paper towels and turned upside down to dry. A ring of CV stained biofilm

cells was seen at the air-medium interface.

Quantification using UV/visible spectrophotometer

The CV in each well solubilized in a 200 ul aliquot of 95% ethanol for 15

minutes at room temperature. In order to obtain enough material for accurate

quantification, 15 wells, representing 3 replicates of 5 wells, were used for

each strain.

A pipette tip was used to remove the CV-stained biofilm from

the walls of each well. Then, the ethanol solution in 5 wells (total volume 1

4

ml) was transferred to a square-bottomed cuvette.

The spectrophotometer reading was taken as follows: a blank was set up

with 95% ethanol for the baseline of zero. The blank and the sample cuvette

containing ethanol/CV solution were read at 600 nm. For each strain and

each time point, the CV in 3 cuvettes was averaged.

All values obtained

for the mutant strains were normalized to those of PA01 wild type. One

drawback to this assay was that the CV stained not only cells, but any

material that adhered to the surface of the plate, including contaminating

material that was not part of the biofilm.

Twitching/swarming Motility Assay

The twitching/swarming motility assay was designed by O’Toole and

Kolter (1998a). Each strain was assessed for twitching motility by stabbing

microcolony cells into very thin 1.5% LB agar plates with a toothpick. Each

plated included a total of 3 stabs of the same strain.

These plates were
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incubated for 24 hours at 37°C. Strains that were capable of twitching

motility formed a haze of growth surrounding the point of inoculation.

For the swarming motility assay, 0.4% LB agar plates were used. A total

of 3 inoculations of 5 ul aliquots of liquid cultures were made per plate and

the plates were incubated at 37°C for 24 hours. The widest expansion of

cells in diameter from the point of inoculation was measured in millimeters

and the colony edges were analyzed for a haze of growth with uneven edges.

Biofilm Antibiotic Resistance Assay.

The biofilm antibiotic resistance assay followed the same protocol as the

96-well plate assay over 24-hour incubation at 37°C. The solution in the

wells was removed by shaking out the liquid into an empty container and

adding fresh media containing different concentrations of antibiotics into the

wells (tetracyclin, ampicilin, kanamycin, and doxycycline). An additional 24

hour Incubation at 37°C was performed and the cells in the wells were
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assessed for their viability by spreading the media into a clean LB plate with

an L-shaped glass-rod. Antibiotic resistance was measured for the minimal

anti-microbial concentration required to kill all biofilm cells.
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Results and Discussion

The liquid culture for the wild-type and PA5210 often expresses a

greenish-yellow shade. From the 96-well microtitre assay indicates that the

PA0686 mutant does not form as strong of a biofilm as the wild-type PA01

strain and the PA5210mutant forms a biofilm that appears to be wider than

the wild-type biofilm. In contrast, the biofilms formed by the PA3102 and

PA3103 mutants look similar to that of the wild type.

Results of the 96-well Microtitre Assay

PA01

PA0686

PA3102

PA3103

PA5210

Figure 2- CV stain of 24-hour biofilm cells in 96-well microtitre plates
(Photograph provided Dr. Kimberly Murphy, 2006).
The differences between PA5210 mutant and wild-type biofilms are

more evident as the incubation time increases. At the 2-hr time point,
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biofilms are barely visible to the eye and the width of biofilm ring of wild-

type and PA5210 mutant biofilms look similar. As time progresses from 4-12

hours, the PA5210 mutant biofilms start to become darker and wider than

wild-type biofilms. At the 24-hr time point, the biofilm ring of PA5210

mutant cells is much wider and darker than wild-type biofilm rings. At all

time points after 2 hr, the PA0686 mutant biofilm are fainter in color than its

wild-type counterpart.

Spectra Results (2006/7/21)
0.500
0.450

Absorption at 600nm

0.400
0.350
0.300
24 hr
0.250
2 hr
0.200
0.150
0.100
0.050
0.000
PA 01 WT

PA 0686

PA 5210

PA 3102

PA 3103

PA01 Strains

Figure 3- Spectrophotometer reading (600nm) of CV-stained biofilm mass.
Wild-type and mutant biofilms were CV stained after 2 hours and 24 hours
in 96-well microtitre plates.
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The data shown in Figure 3 indicates that at 24 hr the PA5210

mutant and the PA3103 mutant generated more biofilm-mass than wild-type

cells, while the PA686 and PA3102 mutants generated less biofilm mass than

wild-type cells. For the two mutants (PA686 and PA5210) with the strongest

biofilm phenotypes, this quantitative data is consistent with the qualitative

data from microtitre assays. However, it should be noted a significant

amount of variability is present in using these quantitative biofilm assays.

For example, as shown in Figure 4, the absorbance data would sometimes

show that the PA5210 mutant produced less 24-hour biofilm mass than wild-

type cells.

In the case of the PA0686 mutant, the absorption data

consistently indicates less biofilm mass than wild-type cells.

One explanation for the variability in PA5210 mutant biofilm mass

readings is that the PA5210 mutant biofilms might be attached more firmly

to the plastic wells than wild-type biofilms. Therefore, it might be very
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difficult to remove the PA5210 mutant biofilms and determine their mass.

Also, it may be that although PA5210 forms wider biofilm than the wild-

type, the biofilm is not as thick as the wild-type.

The results of the twitching and swarming motility assays are very

consistent. As expected, swarming motility is not affected by disruption in

the type-II secretion genes (Figure 4).

In the case of twitching motility,

mutations in the PA686 and PA3103 genes produced defects, whereas

mutations in the PA3102 and PA5210 genes did not (Figure 5).

Results of Motility Assays
Twitch

Swim

+

+

Wild-type

-

Twitch

+

Swim

Twitch

Swim

PA0686

+

+

PA3102

-

Twitch

+

Swim

Twitch

Swim

PA3103

+

+

PA5210

Figure 4- Twitching and swarming motility viewed under the phase-contrast
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microscope (photograph provided by Dr. Kimberly Murphy, 2006). The +
sign indicates that no motility defect was found, while a – sign indicates that
a motility defect was found.
The motility patterns shown in figure 5 show a rounded colony

without a haze of growth for mutant strains PA0686 and PA3103, which

indicates that both strains are completely defective in twitching motility. On

the other hand, PA5210 shows a haze of growth but the edges are smooth

and not jagged as in the wild-type strain and PA3102. This result can be

interpreted as that swarming motility is not affected by type-II secretion

function and the type-IV pili associated movement, such as the twitching

motility. However, defect in twitching motility influences the structure and

development of biofilm depending on specific locus of the disrupted gene.
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Conclusions

A number of proteins are differentially expressed not only between

planktonic bacteria and bacteria within a biofilm, but also between bacteria

within biofilms at different stages of biofilm development (Drenkard, 2003).

From the microtitre plate assay, a progressive increase in biofilm mass is

expected with longer incubation time. The 96-well microtitre assay results

confirmed the pattern of increasing biofilm mass.

The PA5210 mutant was characterized by delayed biofilm formation

since it formed a stronger biofilm than the wild-type only after 4 hours. The

PA0686 mutant was characterized with weak biofilm formation from the

very

beginning

stages.

The

quantification

method

using

the

spectrophotometer had conflicting data with the microtitre assay due to

problems with strongly attached biofilm dispersing in ethanol.

Twitching strains of P. aeruginosa was found to be PA3103 which
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formed a haze of growth that surrounded the point of inoculation, while

PA0686 and PA3103 had none. PA5210 was special in that it formed a haze

but the colony edge was rounded.

Analysis of the biofilm forming phenotype of several strains has

allowed us to further understand the connection between twitching motility

and biofilm formation. The types of assays designed by O’Toole and Kolter

and performed in this study allow for a simple yet effective method for

uncovering genes involved in biofilm formation in P. aeruginosa and other

biofilm-forming pathogens. We found that mutant PA686 is defective for

twitching motility and biofilm development using both qualitative and

quantitative assays. This provides a link between type II secretion

components, twitching motility and biofim development. The PA 3103

mutant also showed a twitching motility defect, but the difference in the

qualitative and quantitative biofilm assay data needs to be resolved. The
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PA3102 and PA5210 mutants showed no twitching motility defects, and as is

the case for the PA3103 mutant, the difference in the qualitative and

quantitative biofilm assay data needs to be resolved.

The next step in the study of gene expressions of P. aeruginosa

biofilm would be to make homologous recombination mutants of the PA01

stains that correspond to the some phenotype as the transposon mutants.

Homologous recombination knockout is a more direct way of gene

disruption that specifies mutation in the conserved domains of the gene

rather than in the unspecified regions as in transposon method. This

information would allow confirmation of the role of specific genes in

biofilm formation.

Due to time limitation, the antibacterial resistance assay was not

done, but this assay will be a useful tool to link future experiments to P.

aeruginosa pathogenesis. The analysis to see if the wider biofilm formed by
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PA5210 is actually more resistant than the wild-type will be effected to see if

biofilm structure PA5210 is as stong as the wild-type. If the PA5210 biofilm

does not hold up to the same antimicrobial agent concentration as the wild-

type, it will mean that the biofilm structure is actually weaker than that of

wild-type due to a defect in twitching motility.

16

References/ Resources

1. Ball, G., Durand, E., Lazdunski, A., and Filloux, A. (2002) A novel type
II secretion system in Pseudomonas aeruginosa. Mol Microbiol 43:
475-485

2. Bodey, G..P., Bolivar, R., Fainstein, V., and Jadeja L. (1983) Infections
caused by Pseudomonas aeruginosa. Rev Infect Dis 5: 279-313.

3. Drenkard, E. (2003) Antimicrobial resistance of Pseudomonas
aeruginosa biofilms. Microbes Infect 5:1213-9.

4. Mikkel Klausen, Arne Heydorn, Paula Ragas, Lotte Lambertsen, Anders
Aaes-Jørgensen, Søren Molin, Tim Tolker-Nielsen (2003) Biofilm
formation by Pseudomonas aeruginosa wild type, flagella and type
IV pili mutants. Molecular Microbiology 48 (6), 1511–1524.

5. Miller, M.J., and Ahearn, D.G. (1987) Adherence of Pseudomonas
aeruginosa to hydrophilic contact lenses and other substrata. J Clin
Microbiol 25: 1392-1397.

6. Fankhauser, D (2005) Spectrophotometer use. Retrieved April 15, 2005,
from University of Cincinnati Clermont College, Department of
Biology Web site:
http://biology.clc.uc.edu/fankhauser/Labs/Microbiology/Growth_C
urve/Spectrophotometer.htm
7. O’Toole, G (2007, May 8) Pseudomonas aeruginosa. Retrieved April 10,

17

2007,

from

Dartmouth

Medical

School

Web

site:

http://www.dartmouth.edu/~gotoole/papage.html

8. O'Toole, G., Kaplan, H.B., and Kolter, R. (2000) Biofilm formation as
microbial development. Annu Rev Microbiol 54: 49-79.

9. O'Toole, G.A., and Kolter, R. (1998a) Flagellar and twitching motility
are necessary for Pseudomonas aeruginosa biofilm development.
Mol Microbiol 30: 295-304.

10. O'Toole, G.A., and Kolter, R. (1998b) Initiation of biofilm formation in
Pseudomonas

fluorescens

WCS365

proceeds

via

multiple,

convergent signaling pathways: a genetic analysis. Mol Microbiol
28: 449-461.

11. Sarlangue J, Brissaud O, and Labreze C. (2006) Clinical features of
Pseudomonas aeruginosa infections. Arch Pediatr 1: S13-6.

12. Sauer, K., and A. K. Camper. 2001. Characterization of phenotypic
changes in Pseudomonas putida in response to surface-associated
growth. J. Bacteriol. 183:6579-6589.

13. Semmler, A.B., Whitchurch, C.B., and Mattick, J.S. (1999) A reexamination of twitching motility in Pseudomonas aeruginosa.
Microbiology 145: 2863-2873.

14. Skerker, J.M., and Berg, H.C. (2001) Direct observation of extension and
retraction of type IV pili. Proc Natl Acad Sci USA 98: 6901–6904.

18

15. Hunt, S.M., Werner, E.M., Huang, E., Hamilton, M.A., and Stewart, P.S.
(2004). Hypothesis for the role of nutrient starvation in biofilm
detachment. Appl Environ Microbiol 70; 7418-25.

16. Russel, Marorie. (1998). Macromolecular assembly and secretion across
the bacterial cell envelope: type II protein secretion systems. J. Mol.
Biol 3; 485-499.

17. GenBank

Overview

(2006) Retrieved

http://www.ncbi.nlm.nih.gov/Genbank/

March

12,

2007,

from

